ADIPOSE TISSUE PARTICLE PROCESSING, TRANSFER AND STORAGE SYSTEM
20210177906 · 2021-06-17
Inventors
Cpc classification
C12N5/0667
CHEMISTRY; METALLURGY
A61K35/44
HUMAN NECESSITIES
A61L27/3604
HUMAN NECESSITIES
C12N2521/00
CHEMISTRY; METALLURGY
C12N2506/1384
CHEMISTRY; METALLURGY
A61L2300/416
HUMAN NECESSITIES
A61L27/3834
HUMAN NECESSITIES
A61L2300/426
HUMAN NECESSITIES
A61M1/00
HUMAN NECESSITIES
A61K35/28
HUMAN NECESSITIES
A61L27/54
HUMAN NECESSITIES
International classification
A61K35/28
HUMAN NECESSITIES
A61K35/44
HUMAN NECESSITIES
A61L27/36
HUMAN NECESSITIES
A61L27/54
HUMAN NECESSITIES
Abstract
An adipose tissue particle processing system includes a container and a filter screen assembly. The filter screen assembly has a first open end configured to receive adipose tissue from a syringe, and a second closed end opposite to the first open end located in the interior of the container. The filter screen assembly further includes a screen portion between the first open end and the second closed end, the screen portion including a plurality of apertures having diameters selected for processing the adipose tissue received through the first open end into controlled fat aspirate particle sizes that are output through the plurality of apertures into the interior of the container.
Claims
1. An adipose tissue particle processing system comprising: a container; and a filter screen assembly at least partially extending into an interior of the container, the filter screen assembly comprising: a first open end configured to receive adipose tissue material from a syringe; a second closed end opposite to the first open end, the second closed end being located in the interior of the container; and a screen portion between the first open end and the second closed end, the screen portion including a plurality of apertures having diameters selected for processing the adipose tissue material received through the first open end into controlled fat aspirate particle sizes that are output through the plurality of apertures into the interior of the container.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0008] The drawings are intended to illustrate embodiments of, but not to limit, the present invention. In the drawings, like reference characters denote corresponding features consistently throughout similar embodiments.
[0009]
[0010]
[0011]
[0012]
[0013]
[0014]
DETAILED DESCRIPTION
[0015] The present disclosure provides an adipose tissue particle processing system that allows a physician to micro-fragment and process adipose tissue into controlled fat aspirate particle sizes for use in autologous fat grafting and/or autologous regenerative treatments containing the autologous fat aspirate particles.
[0016]
[0017] Also, in the embodiment shown (see
[0018] In the embodiment shown, centrifuge tube 14 is made of clear plastic, and has a tapered configuration from its top (where cap/bushing 16 is provided) to its bottom (where a conical tapered end is provided). This is a common configuration for a plastic centrifuge tube, which is readily manufactured by injection molding, for example. In an alternative embodiment, a zero-draft, cylindrical plastic centrifuge tube may be constructed and used, which has no taper from the top to the bottom of the tube, and which has a flat bottom surface rather than a conical tapered end. With such a construction, the cylindrical plastic centrifuge tube could be used with the system described in U.S. patent application Ser. No. 16/295,695 entitled “Aspirating Separated Liquid Components From A Vessel” filed on Mar. 7, 2019, which is incorporated by reference herein in its entirety. In the system described in U.S. patent application Ser. No. 16/295,695, a diaphragm is slidably coupleable to the hollow inner portion of the centrifuge tube, and allows liquid contained in the centrifuge tube to be selectively and controllably aspirated out of the centrifuge tube through the diaphragm.
[0019] Centrifuge tube 14 shown in
[0020] In the embodiment shown (see
[0021] Exemplary dimensions for the various features of cap/bushing 16 are shown in
[0022] Apertures 18 in screen portion 17 of filter screen assembly 12 may be formed in by laser drilling in some embodiments. Example sizes/diameters of apertures 18 may be as large as 4.0 millimeters, as small as 0.2 millimeters, any size/diameter in between, or sizes/diameters larger than 4.0 millimeters or smaller than 0.2 millimeters, depending on the application in which the adipose tissue particle processing system 10 is used.
[0023] In one example, screen portion 17 of filter screen assembly 12 may have an outer diameter of about 0.259 inches (about 6.58 millimeters). In other examples, screen portion 17 of filter screen assembly 12 may have larger or smaller radial dimensions. In some embodiments, filter screen assembly 12 is composed of stainless steel.
[0024] In various embodiments, some of the components of adipose tissue particle sizing system 10 are designed to be reusable components (typically made of stainless steel), while other components are designed to be single-use, disposable components (typically made of plastic). In this context, components described as reusable are capable of being cleaned and sterilized multiple times, such as be a sterilizing autoclave, by enzyme treatment, or by other methods, while single-use, disposable components are provided in sterile packaging for a single use.
[0025] In operation, as shown in
[0026] Once the micro-fragmented “sized” fat aspirate particles are transferred through screen portion 17 of filter screen assembly 12 into centrifuge tube 14, then centrifuge tube 14 may be prepared for centrifugation, by removing components of adipose tissue particle processing system 10, and replacing cap/bushing 16 with a conventional threaded lid. After the micro-fragmented fat aspirate particles are separated by either gravity decantation, or by centrifugation in a centrifuge system, various separated components may be aspirated from centrifuge tube 14. In some embodiments, aspiration may be performed by inserting a transfer cannula into the interior of centrifuge tube 14 and aspirating material through the transfer cannula with a syringe coupled to the transfer cannula (as illustrated in
[0027] Filter screen assembly 12 may be cleaned after use by removing male luer cap 20 from the distal end, and inserting a cannula cleaner that is configured with projecting surfaces such as convex fins into the interior of filter screen assembly 12. Cleaning is performed by scraping, dislodging, and removing debris and contaminants when making direct physical contact with the interior of a cannula device when moved back-and-forth following use of the cannula device, to be moved back and forth to cause frictional engagement with filter screen assembly 12 for cleaning. The cannula cleaner may be made of medical-grade nylon in some embodiments. In some embodiments, the cannula cleaner may be configured as shown and described in U.S. Provisional Application No. 62/855,167 entitled “Method and Apparatus for Cleaning the Interior Cannula of Suction Lipoplasty Cannula Devices and Adipose Tissue and/or Fluid Particle Sizing Devices,” filed on May 31, 2019, which is hereby incorporated by reference.
[0028] Adipose tissue particle processing system 10 described herein allows adipose tissue material to be micro-fragmented (“sized”) to a controllable fat aspirate particle size, with easy connections of components, in a system that minimizes contamination, spillage, and infection issues, while maintaining an essentially closed system during the processing of tissue and/or fluid.
[0029] While various components of adipose tissue particle processing system 10 are shown and/or described in the exemplary embodiments herein as integrated, connected, or separate components, it should be understood that in alternative embodiments, components may be integrally formed, connected, and/or separated in different ways than are shown and described herein, all within the scope and spirit of the present invention. Similarly, the sizes and dimensions of components, both in terms of absolute sizes and relative sizes with respect to other components, may be varied from what is shown and described herein, all within the scope of the present invention.
[0030] While certain example embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of the inventions disclosed herein. Thus, nothing in the foregoing description is intended to imply that any particular feature, characteristic, step, module, or block is necessary or indispensable. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms; furthermore, various omissions, substitutions, and changes in the form of the methods and systems described herein may be made without departing from the spirit of the inventions disclosed herein.